Form 8-K - Current report:
SEC Accession No. 0000950123-06-013710
Filing Date
2006-11-08
Accepted
2006-11-08 12:55:54
Documents
4
Period of Report
2006-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y26885e8vk.htm 8-K 17944
2 EX-99.1: PRESS RELEASE y26885exv99w1.htm EX-99.1 78269
3 EX-99.2: TEXTUAL REPRESENTATION OF PORTIONS OF WEBCAST y26885exv99w2.htm EX-99.2 14411
4 GRAPHIC y26885y2688500.gif GRAPHIC 3308
  Complete submission text file 0000950123-06-013710.txt   117038
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 061196413
SIC: 2835 In Vitro & In Vivo Diagnostic Substances